1. Home
  2. MATH vs STRO Comparison

MATH vs STRO Comparison

Compare MATH & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • STRO
  • Stock Information
  • Founded
  • MATH 2015
  • STRO 2003
  • Country
  • MATH Hong Kong
  • STRO United States
  • Employees
  • MATH N/A
  • STRO N/A
  • Industry
  • MATH Finance/Investors Services
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MATH Finance
  • STRO Health Care
  • Exchange
  • MATH Nasdaq
  • STRO Nasdaq
  • Market Cap
  • MATH 60.8M
  • STRO 69.1M
  • IPO Year
  • MATH N/A
  • STRO 2018
  • Fundamental
  • Price
  • MATH $3.28
  • STRO $1.06
  • Analyst Decision
  • MATH
  • STRO Hold
  • Analyst Count
  • MATH 0
  • STRO 7
  • Target Price
  • MATH N/A
  • STRO $1.97
  • AVG Volume (30 Days)
  • MATH 142.4K
  • STRO 519.9K
  • Earning Date
  • MATH 10-30-2025
  • STRO 08-07-2025
  • Dividend Yield
  • MATH N/A
  • STRO N/A
  • EPS Growth
  • MATH N/A
  • STRO N/A
  • EPS
  • MATH 0.41
  • STRO N/A
  • Revenue
  • MATH $44,567,257.00
  • STRO $104,473,000.00
  • Revenue This Year
  • MATH N/A
  • STRO $65.42
  • Revenue Next Year
  • MATH N/A
  • STRO N/A
  • P/E Ratio
  • MATH $8.00
  • STRO N/A
  • Revenue Growth
  • MATH 165.86
  • STRO N/A
  • 52 Week Low
  • MATH $0.80
  • STRO $0.52
  • 52 Week High
  • MATH $4.17
  • STRO $4.80
  • Technical
  • Relative Strength Index (RSI)
  • MATH 56.90
  • STRO 71.61
  • Support Level
  • MATH $3.05
  • STRO $0.95
  • Resistance Level
  • MATH $3.35
  • STRO $1.07
  • Average True Range (ATR)
  • MATH 0.21
  • STRO 0.09
  • MACD
  • MATH 0.07
  • STRO 0.02
  • Stochastic Oscillator
  • MATH 89.23
  • STRO 68.42

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: